Synbio Tech Inc. (TPEX:1295)

Paramount Global Statistics

Total Valuation

Synbio Tech has a market cap or net worth of TWD 3.77 billion. The enterprise value is 4.36 billion.

Market Cap	3.77B
Enterprise Value	4.36B

Important Dates

The last earnings date was Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	Mar 27, 2025

Share Statistics

Synbio Tech has 34.47 million shares outstanding. The number of shares has increased by 0.09% in one year.

Current Share Class	34.47M
Shares Outstanding	34.47M
Shares Change (YoY)	+0.09%
Shares Change (QoQ)	-0.67%
Owned by Insiders (%)	22.35%
Owned by Institutions (%)	n/a
Float	16.35M

Valuation Ratios

The trailing PE ratio is 20.02 and the forward PE ratio is 17.12.

PE Ratio	20.02
Forward PE	17.12
PS Ratio	3.80
PB Ratio	3.70
P/TBV Ratio	3.79
P/FCF Ratio	n/a
P/OCF Ratio	17.78
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.97, with an EV/FCF ratio of -20.31.

EV / Earnings	25.29
EV / Sales	4.39
EV / EBITDA	15.97
EV / EBIT	22.39
EV / FCF	-20.31

Financial Position

The company has a current ratio of 1.25, with a Debt / Equity ratio of 0.98.

Current Ratio	1.25
Quick Ratio	0.89
Debt / Equity	0.98
Debt / EBITDA	3.66
Debt / FCF	-4.66
Interest Coverage	63.05

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	10.09%
Revenue Per Employee	10.81M
Profits Per Employee	1.87M
Employee Count	92
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Synbio Tech has paid 47.94 million in taxes.

Income Tax	47.94M
Effective Tax Rate	21.75%

Stock Price Statistics

The stock price has increased by +51.37% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+51.37%
50-Day Moving Average	117.06
200-Day Moving Average	85.91
Relative Strength Index (RSI)	43.83
Average Volume (20 Days)	845,108

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Synbio Tech had revenue of TWD 994.50 million and earned 172.45 million in profits. Earnings per share was 5.47.

Revenue	994.50M
Gross Profit	540.22M
Operating Income	194.82M
Pretax Income	220.40M
Net Income	172.45M
EBITDA	269.58M
EBIT	194.82M
Earnings Per Share (EPS)	5.47

Balance Sheet

The company has 413.11 million in cash and 1.00 billion in debt, giving a net cash position of -587.05 million or -17.03 per share.

Cash & Cash Equivalents	413.11M
Total Debt	1.00B
Net Cash	-587.05M
Net Cash Per Share	-17.03
Equity (Book Value)	1.02B
Book Value Per Share	32.53
Working Capital	148.24M

Cash Flow

In the last 12 months, operating cash flow was 212.28 million and capital expenditures -427.06 million, giving a free cash flow of -214.78 million.

Operating Cash Flow	212.28M
Capital Expenditures	-427.06M
Free Cash Flow	-214.78M
FCF Per Share	-6.23

Margins

Gross margin is 54.32%, with operating and profit margins of 19.59% and 17.34%.

Gross Margin	54.32%
Operating Margin	19.59%
Pretax Margin	22.16%
Profit Margin	17.34%
EBITDA Margin	27.11%
EBIT Margin	19.59%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 3.10%.

Dividend Per Share	3.50
Dividend Yield	3.10%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	26.74%
Buyback Yield	-0.09%
Shareholder Yield	3.00%
Earnings Yield	4.57%
FCF Yield	-5.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 6, 2024. It was a forward split with a ratio of 1.02.

Last Split Date	Aug 6, 2024
Split Type	Forward
Split Ratio	1.02

Scores

Synbio Tech has an Altman Z-Score of 1.93 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.93
Piotroski F-Score	4